These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 6141276

  • 1. Mechanisms involved in the hyperglycemic response induced by clonidine and other alpha-2 adrenoceptor agonists.
    DiTullio NW, Cieslinski L, Matthews WD, Storer B.
    J Pharmacol Exp Ther; 1984 Jan; 228(1):168-73. PubMed ID: 6141276
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of the hyperglycemia induced by alpha-2 adrenoceptor agonists.
    Angel I, Bidet S, Langer SZ.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1098-103. PubMed ID: 2901484
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of depression by clonidine of the pressor response to alpha 1-adrenoceptor agonists in pithed rats.
    Nomura S, Sunagane N, Uruno T, Kubota K.
    Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):273-86. PubMed ID: 8829767
    [Abstract] [Full Text] [Related]

  • 4. Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia.
    Angel I, Niddam R, Langer SZ.
    J Pharmacol Exp Ther; 1990 Sep; 254(3):877-82. PubMed ID: 1975624
    [Abstract] [Full Text] [Related]

  • 5. Ultrasonic vocalization production of preweanling rats: effects of central and peripheral administration of alpha2-adrenoceptor agonists.
    Krall CM, Andicochea CT, McDougall SA.
    Eur J Pharmacol; 2005 Jul 11; 517(3):200-7. PubMed ID: 15985263
    [Abstract] [Full Text] [Related]

  • 6. Central alpha-2 adrenoceptor-mediated hypertensive response to clonidine in conscious, normotensive rats.
    Kawasaki H, Takasaki K.
    J Pharmacol Exp Ther; 1986 Mar 11; 236(3):810-8. PubMed ID: 3005557
    [Abstract] [Full Text] [Related]

  • 7. Insulin-dependent attenuation in alpha 2-adrenoreceptor-mediated nociception in experimental diabetes.
    Bitar MS, Pilcher CW.
    Pharmacol Biochem Behav; 1997 Jan 11; 56(1):15-20. PubMed ID: 8981604
    [Abstract] [Full Text] [Related]

  • 8. Role of brain adrenoceptors in the corticortopin-releasing factor-induced central activation of sympatho-adrenomedullary outflow in rats.
    Yorimitsu M, Okada S, Yamaguchi-Shima N, Shimizu T, Arai J, Yokotani K.
    Life Sci; 2008 Feb 27; 82(9-10):487-94. PubMed ID: 18201726
    [Abstract] [Full Text] [Related]

  • 9. Alpha adrenoceptor subtypes involved in the emetic action in dogs.
    Hikasa Y, Ogasawara S, Takase K.
    J Pharmacol Exp Ther; 1992 May 27; 261(2):746-54. PubMed ID: 1349647
    [Abstract] [Full Text] [Related]

  • 10. The effects of alpha-2 agonists and antagonists on gastric acid secretion.
    Bernardini C, Del Tacca M, Soldani G, Martinotti E.
    Arch Int Pharmacodyn Ther; 1986 May 27; 281(1):134-44. PubMed ID: 2875694
    [Abstract] [Full Text] [Related]

  • 11. St-93 hyperglycemia in Wistar rats.
    Thomas GP, Krishnamurthy A, Thapar GS, Varma RK.
    Arch Int Pharmacodyn Ther; 1992 May 27; 315():79-86. PubMed ID: 1417366
    [Abstract] [Full Text] [Related]

  • 12. Pre- and postsynaptic mechanisms in the clonidine- and oxymetazoline-induced inhibition of gastric motility in the rat.
    Zádori ZS, Shujaa N, Fülöp K, Dunkel P, Gyires K.
    Neurochem Int; 2007 Oct 27; 51(5):297-305. PubMed ID: 17664022
    [Abstract] [Full Text] [Related]

  • 13. Effects of alpha-adrenoceptor agonists and antagonists on thyroid hormone secretion.
    Ahrén B.
    Acta Endocrinol (Copenh); 1985 Feb 27; 108(2):184-91. PubMed ID: 2857513
    [Abstract] [Full Text] [Related]

  • 14. The role of NO-cGMP pathway and potassium channels on the relaxation induced by clonidine in the rat mesenteric arterial bed.
    Pimentel AM, Costa CA, Carvalho LC, Brandão RM, Rangel BM, Tano T, Soares de Moura R, Resende AC.
    Vascul Pharmacol; 2007 May 27; 46(5):353-9. PubMed ID: 17258511
    [Abstract] [Full Text] [Related]

  • 15. Effect of clonidine on colonic motility in rats.
    Umezawa T, Guo S, Jiao Y, Hisamitsu T.
    Auton Neurosci; 2003 Aug 29; 107(1):32-6. PubMed ID: 12927224
    [Abstract] [Full Text] [Related]

  • 16. Alpha 2-adrenoceptor-blocking properties of midaglizole (DG-5128) in rats.
    Hirohashi M, Tanaka M, Suzuki I, Akashi A.
    Arch Int Pharmacodyn Ther; 1990 Aug 29; 306():75-86. PubMed ID: 1981668
    [Abstract] [Full Text] [Related]

  • 17. The contribution of alpha-1 and alpha-2 adrenoceptors in peripheral imidazoline and adrenoceptor agonist-induced nociception.
    Dogrul A, Coskun I, Uzbay T.
    Anesth Analg; 2006 Aug 29; 103(2):471-7, table of contents. PubMed ID: 16861437
    [Abstract] [Full Text] [Related]

  • 18. alpha2-Adrenoceptor subsensitivity in mesenteric vascular bed of cholestatic rats: the role of nitric oxide and endogenous opioids.
    Borhani AA, Houshmand G, Samini M, Namiranian K, Hajrasouliha AR, Tavakoli S, Ebrahimi F, Dehpour AR.
    Eur J Pharmacol; 2005 May 09; 514(2-3):183-9. PubMed ID: 15910805
    [Abstract] [Full Text] [Related]

  • 19. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    Seidel WF, Maze M, Dement WC, Edgar DM.
    J Pharmacol Exp Ther; 1995 Oct 09; 275(1):263-73. PubMed ID: 7562559
    [Abstract] [Full Text] [Related]

  • 20. Effects of alpha-adrenoceptor antagonists administered intraventricularly on central hypotensive action of clonidine and on central hypertensive action of methoxamine in rabbits.
    Kim YI, Paik YH, Kang SS, Kim JH.
    Arch Int Pharmacodyn Ther; 1982 May 09; 257(1):66-76. PubMed ID: 6126161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.